| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 77357-00-7 | Glycine,N-[(3-nitro-2-pyridinyl)thio]-; NPys-GlyCINE; NPys-Gly-OH; N-ALPHA-3-NITRO-2-PYRIDINE-SULFENYL-GLYCINE; 3-NITRO-2-PYRIDINE-SULFENYL GLYCINE; N-(3-NITRO-2-PYRIDINESULFENYL)GLYCINE | ![]() | C7H7N3O4S | 详情 | 供应商 | |
| 89422-41-3 | Glycine,N-(trifluoroacetyl)-L-cysteinyl-, methyl ester, bimol. (1®1')-disulfide (9CI); (TFA-Cys-Gly-OME)2; (N-TRIFLUOROACETYL-L-CYSTEINYL)GLYCINE METHYL ESTER, (1-1’) DISULPHIDE; (Tfa-Cys-Gly-OMe)2 (Disulfide bond) | ![]() | C8H11F3N2O4S3 | 详情 | 供应商 | |
| 99026-77-4 | GLY-Lys-Gly-ALA-GLY-LEU-SER-LEU-SER-ARG-PHE-SER-TRP-GLY-ALA; GLY-Lys-Gly-ALA-GLY-LEU-SER-LEU-SER-ARG-PHE-SER-TRP-GLY-ALA; [ALA107]-MBP (104-118); [ALA107]-MBP FRAGMENT 104-118; [ALA107]-MYELIN BASIC PROTEIN FRAGMENT 104-118; [Ala107]-Myelin Basic Protein (104-118) | ![]() | C67H104N20O19 | 详情 | 供应商 | |
| 83283-22-1 | N-BOC-S-BZL-L-Cys-Gly-OBZL; N-BOC-S-BZL-L-Cys-Gly-OBZL; N-t-Butoxycarbonyl-S-benzyl-L-cysteinyl-glycine, Benzyl Ester | ![]() | C24H30N2O5S | 详情 | 供应商 | |
| 874462-72-3 | N-CBZ-O-BZL-L-GLU-S-BZL-L-Cys-Gly[13C2,15N]-OBZL; N-CBZ-O-BZL-L-GLU-S-BZL-L-Cys-Gly[13C2,15N]-OBZL; N-Benzyloxycarbonyl-O-benzyl-g-L-glutamyl-S-benzyl-L-cysteinyl-glycine[13C2,15N], Benzyl Ester; N-Benzyloxycarbonyl-O-benzyl--L-glutamyl-S-benzyl-L-cysteinyl-glycine[13C2,15N], Benzyl Ester; N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzlCAS Number: | ![]() | C37(13C)2H41N2(15N)O8S | 详情 | 供应商 | |
| 97924-38-4 | N-CBZ-O-BZL-L-GLU-S-BZL-L-Cys-Gly-OBZL; N-CBZ-O-BZL-L-GLU-S-BZL-L-Cys-Gly-OBZL; N-Benzyloxycarbonyl-O-benzyl-g-L-glutamyl-S-benzyl-L-cysteinyl-glycine, Benzyl Ester; N-Benzyloxycarbonyl-O-benzyl--L-glutamyl-S-benzyl-L-cysteinyl-glycine, Benzyl Ester | ![]() | C39H41N3O8S | 详情 | 供应商 | |
| 104914-40-1 | Cys-Gly-TYR-GLY-PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLY-GLY | Cys-Gly-TYR-GLY-PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLY-GLY; SV40 NUCLEAR TRANSPORT SIGNAL PEPTIDE ANALOG; C-G-Y-G-P-K-K-K-R-K-V-G-G; Cys-Gly-TYR-GLY-PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLY-GLY; H-Cys-Gly-TYR-GLY-PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLY-GLY-OH; cys-Gly-tyr-gly-pro-lys-lys-lys-arg-*lys-val-gly-; Cys-Gly-TYR-GLY-PRO-LYS-LYS-LYS-ARG-LYS- VAL-GLY-GL | ![]() | C60H104N20O15S | 详情 | 供应商 |
| 40719-58-2 | 赖氨酸-甘氨酸二肽 | H-Lys-Gly-OH HCL; Lys-Gly HYDROCHLORIDE; L-Lys-Gly HCL; H-Lys-Gly-OH HCL; Lys-Gly HYDROCHLORIDE CRYSTALLINE; lys-GlyHClcrystalline; H-Lys-Gly-OH hydrochloride; Lys-Gly | ![]() | C8H18ClN3O3 | 详情 | 供应商 |
| 60786-59-6 | (THR4,GLY7)-OXYTOCIN | CYS-TYR-ILE-THR-ASN-Cys-Gly-LEU-GLY-NH2; thr(4)-gly(7)-oxytoci; [THR4, GLY7] OT; [THR4, GLY7]-OXYTOCIN; CYS-TYR-ILE-THR-ASN-Cys-Gly-LEU-GLY-NH2; H-CYS-TYR-ILE-THR-ASN-Cys-Gly-LEU-GLY-NH2; H-CYS-TYR-ILE-THR-ASN-Cys-Gly-LEU-GLY-NH2, (DISULFIDE BOND); 3,3-DiallylthiacarbocyanineBromide | ![]() | C39H63N11O12S2 | 详情 | 供应商 |
| 475221-20-6 | AC-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; ARG-ILE-TYR-Lys-Gly-VAL-ILE-GLN-ALA-ILE-GLN-LYS-SER-ASP-GLU-GLY-HIS-PRO-PHE-ARG-ALA-TYR-LEU-GLU-SER-GLU-VAL-ALA-ILE-SER-GLU-GLU-LEU-VAL-GLN-LYS-TYR-SER-ASN-SER-NH2; AC-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; NEP1-40; NOGO-66 (1-40); NOGO-66 (1-40) ANTAGONIST PEPTIDE; NOGO EXTRACELLULAR PEPTIDE, 1-40; M.W. 4625.11 C206H324N56O65 | ![]() | C206H324N56O65 | 详情 | 供应商 | |
| 112955-31-4 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS- | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; ala-val-ser-glu-his-gln-leu-leu-his-asp-lys-Gly-lys-ser-ile-gln-asp-leu-arg-arg-arg-phe-phe-leu-his-his-leu-ile-ala-glu-ile-his-thr-ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 无 | C180H288N58O47 | 详情 | 供应商 |
| 133605-54-6 | Val-Thr-Lys-Gly | ![]() | C17H33N5O6 | 详情 | 供应商 | |
| 144189-71-9 | 淀粉Β-蛋白(22-35); 淀粉Β-蛋白(22-35); H-EDVLGSNKGAIIGLM-OH | H-GLU-ASP-VAL-GLY-SER-ASN-Lys-Gly-ALA-ILE-ILE-GLY-LEU-MET-OH; AMYLOID BETA-PROTEIN FRAGMENT 22-35; AMYLOID BETA-PROTEIN (22-35); EDVGSNKGAIIGLM; H-GLU-ASP-VAL-GLY-SER-ASN-Lys-Gly-ALA-ILE-ILE-GLY-LEU-MET-OH; GLU-ASP-VAL-GLY-SER-ASN-Lys-Gly-ALA-ILE-ILE-GLY-LEU-MET; BETA-AMYLOID (22-35); AMYLOID B-PROTEIN FRAGMENT 22-35; amyloid β-protein fragment 22-35 | ![]() | C59H102N16O21S | 详情 | 供应商 |
| 217082-60-5 | 人牛吡啶APELIN-13; 人牛吡啶APELIN-13; GLP-ARG-PRO-ARG-LEU-SER-HIS-Lys-Gly-PRO-MET-PRO-PHE: GRPRLSHKGPM | PYR-ARG-PRO-ARG-LEU-SER-HIS-Lys-Gly-PRO-MET-PRO-PHE-OH; [PE]APELIN-13, HUMAN, BOVINE; PYR-RPRLSHKGPMPF-OH; PYR-ARG-PRO-ARG-LEU-SER-HIS-Lys-Gly-PRO-MET-PRO-PHE; PYR-ARG-PRO-ARG-LEU-SER-HIS-Lys-Gly-PRO-MET-PRO-PHE-OH; [PYR1]-APELIN-13; (PYR1)-APELIN-13 (HUMAN, BOVINE); (PYR1)-APELIN-13 (HUMAN, BOVINE, MOUSE, RAT); [PGLU1]APELIN (24-36), HUMAN, BOVINE | ![]() | C69H108N22O16S | 详情 | 供应商 |
| 600171-68-4 | ORPHAN GPCR SP9155 AGONIST P518 (HUMAN) | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-Lys-Gly-GLY-PHE-SER-PHE-AR; H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-Lys-Gly-GLY-PHE-SER-PHE-ARG-PHE-NH2; ORPHAN GPCR SP9155 AGONIST P518 (HUMAN); ORPHAN G-PROTEIN COUPLED RECEPTOR SP9155 AGONIST PEPTIDE P518 (HUMAN); P518 (HUMAN); Orphan GPCR SP9155 Agonist P518 (huMan) P518 (huMan), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (huMan) | ![]() | 详情 | 供应商 | |
| 185032-24-0 | TYR-Lys-Gly-(CYCLO(GLU26-LYS29),PRO34)-NEUROPEPTIDE Y (25-36) | H-TYR-Lys-Gly-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2; H-TYR-Lys-Gly-ARG-CYCLO(-GAMMA-GLU-TYR-ILE-EPSILON-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2; H-TYR-Lys-Gly-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2; TYR-Lys-Gly-ARG-(GLU26,LYS29,PRO34)-NEURO-PEPTIDE Y (26-36); TYR-Lys-Gly-(CYCLO(GLU26,LYS29),PRO34)-NEUROPEPTIDE Y (25-36); TYR-Lys-Gly-(CYCLO(GLU26,LYS29),PRO34)-NPY (25-36) | ![]() | 详情 | 供应商 | |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-Gly-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |